Clinical trial
Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small…
NCT00006229 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00006229 |
|---|---|
| Title | Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer |
| Official title | A Phase II/III Double Blind Randomized Trial of BMS-275291 vs. Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-small Cell Lung Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel, rebimastat |
| Enrollment | 774 |
| Start date | Apr 4, 2000 |
| Primary completion | Dec 10, 2003 |
| Completion | Feb 10, 2009 |
| First posted | Jul 25, 2003 |
| Last update posted | Apr 6, 2020 |
| Countries | Austria, Belgium, Canada, Finland, France, Germany, Italy, Netherlands, Poland, Portugal, Spain, Switzerland and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: